High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning
Ran Reshef(Abramson Cancer Center), David Porter(University of Pennsylvania), James K. Mangan(University of Pennsylvania), Marlise R. Luskin(Dana-Farber Cancer Institute), Edward A. Stadtmauer(University of Pennsylvania), Taku Kambayashi(California University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Robert H. Vonderheide(University of Pennsylvania), Alison W. Loren(University of Pennsylvania), Rosemarie Mick(University of Pennsylvania), Mary Sell(University of Pennsylvania), Lee P. Richman(University of Pennsylvania), Sunita D. Nasta(University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Amy Gao(University of Pennsylvania), Austin P. Huffman, Selina M. Luger(University of Pennsylvania)
Cited by 60
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907